Search | Clinical Trials Finder

These results were retrieved from the live ClinicalTrials.gov registry. Filters and sort order apply to this result list.

ClinicalTrials.gov public records Last synced Nov 15, 2026, 12:41 AM EST

All trial information on this site comes from the official ClinicalTrials.gov public API (clinicaltrials.gov/api/v2), run by the U.S. National Library of Medicine. We only display that public information; we do not add opinions, endorsements, or any other intent. Always review the official ClinicalTrials.gov record for the latest information.

Showing 2665–2688 of 18,280 matching trials from the live ClinicalTrials.gov search.

Filters: Intervention: Controlled Group Clear all

Conditions: Ventricular Arrhythmia
Interventions: Eleclazine, Placebo to match eleclazine; Drug
Lead sponsor: Gilead Sciences; Industry
Eligibility: 18 Years to 80 Years
Enrollment: 313 participants
Healthy volunteers: Healthy volunteers not accepted
Timeline: 2014 – 2016
U.S. locations: 37
States / cities: Mesa, Arizona • Long Beach, California • Los Angeles, California + 32 more

Conditions: Heart Failure
Interventions: Sensor-controlled digital game (SCDG), Sensor Only; Behavioral
Lead sponsor: University of Texas at Austin; Other
Eligibility: 45 Years and older
Enrollment: 200 participants
Healthy volunteers: Healthy volunteers not accepted
Timeline: 2022 – 2026
U.S. locations: 1
States / cities: Austin, Texas

Conditions: Autism Spectrum Disorder (ASD)
Interventions: Wellness Enhancing Physical Activity for Young Children (WE PLAY), Non-Physical Activity Online Training; Behavioral
Lead sponsor: Northeastern University; Other
Eligibility: 33 Months to 71 Months
Enrollment: 300 participants
Healthy volunteers: Healthy volunteers not accepted
Timeline: 2026 – 2030
U.S. locations: 3
States / cities: Boston, Massachusetts • University Park, Pennsylvania

Conditions: HIV Prevention, HCV, Opioid Use, Intravenous Drug Usage
Interventions: ARTAS Adapted Patient Navigation, Adherence Counseling; Behavioral
Lead sponsor: Columbia University; Other
Eligibility: 18 Years to 64 Years
Enrollment: 446 participants
Healthy volunteers: Accepts healthy volunteers
Timeline: 2019 – 2026
U.S. locations: 2
States / cities: Miami, Florida • New York, New York

Conditions: Sanfilippo Syndrome, Mucopolysaccharidosis III
Interventions: Epidiolex, Placebo; Drug
Lead sponsor: Lundquist Institute for Biomedical Innovation at Harbor-UCLA Medical Center; Other
Eligibility: 4 Years and older
Enrollment: 35 participants
Healthy volunteers: Healthy volunteers not accepted
Timeline: 2026 – 2028
U.S. locations: 1
States / cities: Torrance, California

Conditions: Back Pain
Interventions: Not listed
Lead sponsor: Kaiser Permanente; Other
Eligibility: 18 Years and older
Enrollment: 1,760 participants
Healthy volunteers: Healthy volunteers not accepted
Timeline: 2013 – 2016
U.S. locations: 1
States / cities: Seattle, Washington

Conditions: Bradycardia, Slow Heart Beat
Interventions: Implantable Pulse Generator (IPG) and Pacing Leads (wires), Magnetic Resonance Imaging (MRI) scan; Device · Other
Lead sponsor: Medtronic Cardiac Rhythm and Heart Failure; Industry
Eligibility: Not listed
Enrollment: 484 participants
Healthy volunteers: Healthy volunteers not accepted
Timeline: 2007 – 2010
U.S. locations: 15
States / cities: Redwood City, California • Salinas, California • Orlando, Florida + 12 more

Conditions: HIV
Interventions: Relationship Strengthening HIV Prevention Intervention, Parenting Program Intervention; Behavioral
Lead sponsor: Yale University; Other
Eligibility: 14 Years and older
Enrollment: 100 participants
Healthy volunteers: Accepts healthy volunteers
Timeline: 2012 – 2020
U.S. locations: 1
States / cities: New Haven, Connecticut

Conditions: Hyperkalemia
Interventions: Patiromer, Placebos; Drug
Lead sponsor: Vifor Pharma, Inc.; Industry
Eligibility: 18 Years and older
Enrollment: 1,195 participants
Healthy volunteers: Healthy volunteers not accepted
Timeline: 2019 – 2021
U.S. locations: 133
States / cities: Alexander City, Alabama • Huntsville, Alabama • Phoenix, Arizona + 110 more

Conditions: Development, Infant
Interventions: Maternal Scent; Other
Lead sponsor: Columbia University; Other
Eligibility: 30 Weeks to 36 Weeks
Enrollment: 78 participants
Healthy volunteers: Healthy volunteers not accepted
Timeline: 2019 – 2021
U.S. locations: 1
States / cities: New York, New York

Conditions: Emergency Contraception, Contraception
Interventions: Depot-Medroxyprogestereone Acetate; Drug
Lead sponsor: University of Southern California; Other
Eligibility: 18 Years to 39 Years · Female only
Enrollment: 30 participants
Healthy volunteers: Accepts healthy volunteers
Timeline: 2018 – 2020
U.S. locations: 1
States / cities: Los Angeles, California

Conditions: Traumatic Brain Injury, Brain Injuries, Brain Injury, Vascular
Interventions: Transcranial Doppler; Device
Lead sponsor: University of Texas Southwestern Medical Center; Other
Eligibility: 28 Days to 18 Years
Enrollment: 29 participants
Healthy volunteers: Accepts healthy volunteers
Timeline: 2018 – 2020
U.S. locations: 1
States / cities: Dallas, Texas

Conditions: HIV Prevention
Interventions: STARS: Sistas Talking About Real Solutions, General Health & Nutrition; Behavioral
Lead sponsor: Emory University; Other
Eligibility: 18 Years to 29 Years · Female only
Enrollment: 855 participants
Healthy volunteers: Accepts healthy volunteers
Timeline: 2002 – 2006
U.S. locations: 1
States / cities: Atlanta, Georgia

Conditions: Frail Older Adults
Interventions: Progressive Multi-Component Intervention, Usual Care; Behavioral
Lead sponsor: University of Colorado, Denver; Other
Eligibility: 65 Years and older
Enrollment: 30 participants
Healthy volunteers: Healthy volunteers not accepted
Timeline: 2011 – 2017
U.S. locations: 2
States / cities: Aurora, Colorado • Glenside, Pennsylvania

Conditions: Chronic Pain, Mental Health Disorders, Behavioral Health Challenges, Ecological Momentary Assessment Best Practices
Interventions: Digital Biopsychosocial Conversational Data Collection Software, Standard Digital Questionnaire Data Collection; Other
Lead sponsor: AugMend Health Inc.; Industry
Eligibility: 18 Years and older
Enrollment: 100 participants
Healthy volunteers: Healthy volunteers not accepted
Timeline: 2025 – 2026
U.S. locations: 1
States / cities: Cambridge, Massachusetts

Conditions: Infertility
Interventions: Follitropin delta, Placebo; Drug · Other
Lead sponsor: Ferring Pharmaceuticals; Industry
Eligibility: 18 Years to 34 Years · Female only
Enrollment: 579 participants
Healthy volunteers: Healthy volunteers not accepted
Timeline: 2018 – 2020
U.S. locations: 23
States / cities: Tempe, Arizona • Encino, California • Farmington, Connecticut + 20 more

Conditions: Proximal Muscle Strength, Proximal Muscle Lengthening
Interventions: myofascial release, blood flow restriction; Other · Device
Lead sponsor: University of Tennessee; Other
Eligibility: 18 Years to 30 Years
Enrollment: 60 participants
Healthy volunteers: Accepts healthy volunteers
Timeline: 2023 – 2024
U.S. locations: 1
States / cities: Memphis, Tennessee

Conditions: Communication Research
Interventions: nurse-led communication strategy; Behavioral
Lead sponsor: State University of New York at Buffalo; Other
Eligibility: 18 Years and older
Enrollment: 41 participants
Healthy volunteers: Accepts healthy volunteers
Timeline: 2020 – 2021
U.S. locations: 1
States / cities: Buffalo, New York

Conditions: Spinal Cord Injuries, Neuromodulation
Interventions: Transcutaneous Spinal cord Stimulation, Epidural Spinal Stimulation (ESS); Device
Lead sponsor: The Methodist Hospital Research Institute; Other
Eligibility: 22 Years to 75 Years
Enrollment: 60 participants
Healthy volunteers: Healthy volunteers not accepted
Timeline: 2023 – 2027
U.S. locations: 1
States / cities: Houston, Texas

Conditions: Macular Degeneration, Central Visual Impairment
Interventions: 'Scotoma awareness' Training, Control Training; Behavioral
Lead sponsor: University of Alabama at Birmingham; Other
Eligibility: 18 Years to 89 Years
Enrollment: 21 participants
Healthy volunteers: Healthy volunteers not accepted
Timeline: 2022 – 2025
U.S. locations: 1
States / cities: Birmingham, Alabama

Conditions: Lung Cancer
Interventions: Group A - Device guided breathing low dose, Group B - Device guided breathing high dose, Group C - Usual Breathing Control Group; Device
Lead sponsor: Wake Forest University Health Sciences; Other
Eligibility: 18 Years and older
Enrollment: 46 participants
Healthy volunteers: Healthy volunteers not accepted
Timeline: 2015 – 2019
U.S. locations: 11
States / cities: Rehoboth Beach, Delaware • Wichita, Kansas • Coon Rapids, Minnesota + 7 more

Conditions: HIV Preexposure Prophylaxis
Interventions: ISL, FTC/TDF, FTC/TAF, Placebo to ISL, Placebo to FTC/TDF, Placebo to FTC/TAF; Drug
Lead sponsor: Merck Sharp & Dohme LLC; Industry
Eligibility: 16 Years and older · Male only
Enrollment: 494 participants
Healthy volunteers: Accepts healthy volunteers
Timeline: 2021 – 2023
U.S. locations: 15
States / cities: Birmingham, Alabama • Los Angeles, California • San Francisco, California + 11 more

Conditions: Familial Adenomatous Polyposis, Map Syndrome, Lynch Syndrome, Hnpcc, Colorectal Cancer
Interventions: Epi proColon Testing; Other
Lead sponsor: University of Pennsylvania; Other
Eligibility: 18 Years and older
Enrollment: 24 participants
Healthy volunteers: Accepts healthy volunteers
Timeline: 2014 – 2019
U.S. locations: 1
States / cities: Philadelphia, Pennsylvania

Conditions: Dementia, Mild Cognitive Impairment (MCI), Alzheimer Disease
Interventions: Psychoeducational skills training intervention; Behavioral
Lead sponsor: Arizona State University; Other
Eligibility: 60 Years and older
Enrollment: 70 participants
Healthy volunteers: Healthy volunteers not accepted
Timeline: 2025 – 2027
U.S. locations: 1
States / cities: Phoenix, Arizona

Search by objective public record fields.

Evaluating Ventricular Arrhythmia in Subjects With Implantable Cardioverter Defibrillator or Cardiac Resynchronization Therapy-Defibrillator

Sensor-controlled Digital Game for Heart Failure Self-management: A Clinical Trial

Promoting Physical Activity Among Young Children With Autism

Integrated HIV Prevention and HCV Care for PWID

Study of Cannabidiol in Sanfilippo Syndrome

Matching Appropriate Treatments to Consumers' Healthcare Needs, MATCH

EMRI SureScan™ Clinical Study

A Couple-Based Relationship Strengthening HIV Intervention for Young Parents

Patiromer for the Management of Hyperkalemia in Subjects Receiving RAASi Medications for the Treatment of Heart Failure (DIAMOND)

The Effect of Maternal Scent on Sleep Wake States

Depot Medroxyprogesterone Acetate as Emergency Contraception

Multimodal Monitoring of Cerebral Autoregulation After Pediatric Brain Injury

S.T.A.R.S.: Sistas Talking About Real Solutions

Improving Function, Participation and Function After Acute Hospitalization in Older Adults

Evaluating the Acceptability, Feasibility and Usability of Various Conversational Data Collection Software

Recombinant FSH Investigation in the Treatment of Infertility With Assisted Reproductive Technology (ART) (RITA-1)

Investigating Proximal Muscle Strength Effects by Incorporating Proximal Muscle Lengthening

Using a Nurse-Led Communication Strategy for Surrogates in the Intensive Care Unit

Harnessing Neuroplasticity of Postural Sensorimotor Networks Using Non-Invasive Spinal Neuromodulation to Maximize Functional Recovery After Spinal Cord Injury

Scotoma Perimetry Oculomotor Training

Reducing Lung Cancer-Related Anxiety (RELAX)

Oral Islatravir (MK-8591) Once-Monthly as Preexposure Prophylaxis (PrEP) in Men and Transgender Women Who Are at High Risk for HIV-1 Infection (MK-8591-024)

Preliminary Evaluation of Septin9 in Patients With Hereditary Colon Cancer Syndromes

Early-Stage Partner in Care Living Alone Plus